Literature DB >> 33441552

Single cell transcriptomic analysis of human pluripotent stem cell chondrogenesis.

Chia-Lung Wu1,2,3, Amanda Dicks1,2,4, Nancy Steward1,2, Ruhang Tang1,2, Dakota B Katz1,2,4, Yun-Rak Choi1,2,5, Farshid Guilak6,7,8.   

Abstract

The therapeutic application of human induced pluripotent stem cells (hiPSCs) for cartilage regeneration is largely hindered by the low yield of chondrocytes accompanied by unpredictable and heterogeneous off-target differentiation of cells during chondrogenesis. Here, we combine bulk RNA sequencing, single cell RNA sequencing, and bioinformatic analyses, including weighted gene co-expression analysis (WGCNA), to investigate the gene regulatory networks regulating hiPSC differentiation under chondrogenic conditions. We identify specific WNTs and MITF as hub genes governing the generation of off-target differentiation into neural cells and melanocytes during hiPSC chondrogenesis. With heterocellular signaling models, we further show that WNT signaling produced by off-target cells is responsible for inducing chondrocyte hypertrophy. By targeting WNTs and MITF, we eliminate these cell lineages, significantly enhancing the yield and homogeneity of hiPSC-derived chondrocytes. Collectively, our findings identify the trajectories and molecular mechanisms governing cell fate decision in hiPSC chondrogenesis, as well as dynamic transcriptome profiles orchestrating chondrocyte proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33441552      PMCID: PMC7806634          DOI: 10.1038/s41467-020-20598-y

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  59 in total

1.  High-depth transcriptomic profiling reveals the temporal gene signature of human mesenchymal stem cells during chondrogenesis.

Authors:  Nguyen P T Huynh; Bo Zhang; Farshid Guilak
Journal:  FASEB J       Date:  2018-07-09       Impact factor: 5.191

Review 2.  Functions of AP1 (Fos/Jun) in bone development.

Authors:  E F Wagner
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 3.  Genome Engineering for Personalized Arthritis Therapeutics.

Authors:  Shaunak S Adkar; Jonathan M Brunger; Vincent P Willard; Chia-Lung Wu; Charles A Gersbach; Farshid Guilak
Journal:  Trends Mol Med       Date:  2017-09-05       Impact factor: 11.951

4.  Generation of scaffoldless hyaline cartilaginous tissue from human iPSCs.

Authors:  Akihiro Yamashita; Miho Morioka; Yasuhito Yahara; Minoru Okada; Tomohito Kobayashi; Shinichi Kuriyama; Shuichi Matsuda; Noriyuki Tsumaki
Journal:  Stem Cell Reports       Date:  2015-02-26       Impact factor: 7.765

5.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

6.  Evidence That Rat Chondrocytes Can Differentiate Into Perichondrial Cells.

Authors:  Stephan-Stanislaw Späth; Anenisia C Andrade; Michael Chau; Marta Baroncelli; Ola Nilsson
Journal:  JBMR Plus       Date:  2018-06-07

7.  Prospective isolation of chondroprogenitors from human iPSCs based on cell surface markers identified using a CRISPR-Cas9-generated reporter.

Authors:  Amanda Dicks; Chia-Lung Wu; Nancy Steward; Shaunak S Adkar; Charles A Gersbach; Farshid Guilak
Journal:  Stem Cell Res Ther       Date:  2020-02-18       Impact factor: 8.079

8.  The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists.

Authors:  Da Wei Huang; Brad T Sherman; Qina Tan; Jack R Collins; W Gregory Alvord; Jean Roayaei; Robert Stephens; Michael W Baseler; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

Review 9.  Considerations in hiPSC-derived cartilage for articular cartilage repair.

Authors:  Akihiro Yamashita; Yoshihiro Tamamura; Miho Morioka; Peter Karagiannis; Nobuyuki Shima; Noriyuki Tsumaki
Journal:  Inflamm Regen       Date:  2018-10-04

10.  Molecular Criteria for Defining the Naive Human Pluripotent State.

Authors:  Thorold W Theunissen; Marc Friedli; Yupeng He; Evarist Planet; Ryan C O'Neil; Styliani Markoulaki; Julien Pontis; Haoyi Wang; Alexandra Iouranova; Michaël Imbeault; Julien Duc; Malkiel A Cohen; Katherine J Wert; Rosa Castanon; Zhuzhu Zhang; Yanmei Huang; Joseph R Nery; Jesse Drotar; Tenzin Lungjangwa; Didier Trono; Joseph R Ecker; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2016-07-14       Impact factor: 25.269

View more
  19 in total

Review 1.  Understanding the Transcriptomic Landscape to Drive New Innovations in Musculoskeletal Regenerative Medicine.

Authors:  Stacey M Thomas; Cheryl L Ackert-Bicknell; Michael J Zuscik; Karin A Payne
Journal:  Curr Osteoporos Rep       Date:  2022-02-14       Impact factor: 5.096

2.  Transcriptional dynamics of colorectal cancer risk associated variation at 11q23.1 correlate with tuft cell abundance and marker expression in silico.

Authors:  Bradley T Harris; Vidya Rajasekaran; James P Blackmur; Alan O'Callaghan; Kevin Donnelly; Maria Timofeeva; Peter G Vaughan-Shaw; Farhat V N Din; Malcolm G Dunlop; Susan M Farrington
Journal:  Sci Rep       Date:  2022-08-10       Impact factor: 4.996

3.  Bioengineering Human Cartilage-Bone Tissues for Modeling of Osteoarthritis.

Authors:  Josephine Y Wu; Gordana Vunjak-Novakovic
Journal:  Stem Cells Dev       Date:  2022-03-14       Impact factor: 4.390

4.  GDF5+ chondroprogenitors derived from human pluripotent stem cells preferentially form permanent chondrocytes.

Authors:  Azim Pothiawala; Berke E Sahbazoglu; Bryan K Ang; Nadine Matthias; Guangsheng Pei; Qing Yan; Brian R Davis; Johnny Huard; Zhongming Zhao; Naoki Nakayama
Journal:  Development       Date:  2022-06-06       Impact factor: 6.862

Review 5.  Single Cell Omics for Musculoskeletal Research.

Authors:  Muhammad Farooq Rai; Chia-Lung Wu; Terence D Capellini; Farshid Guilak; Amanda R Dicks; Pushpanathan Muthuirulan; Fiorella Grandi; Nidhi Bhutani; Jennifer J Westendorf
Journal:  Curr Osteoporos Rep       Date:  2021-02-09       Impact factor: 5.096

6.  Prospective Isolation and Characterization of Chondroprogenitors from Human Chondrocytes Based on CD166/CD34/CD146 Surface Markers.

Authors:  Elizabeth Vinod; Kawin Padmaja; Abel Livingston; Jithu Varghese James; Soosai Manickam Amirtham; Solomon Sathishkumar; Boopalan Ramasamy; Grace Rebekah; Alfred Job Daniel; Upasana Kachroo
Journal:  Cartilage       Date:  2021-09-16       Impact factor: 3.117

Review 7.  Application of Induced Pluripotent Stem Cells for Disease Modeling and 3D Model Construction: Focus on Osteoarthritis.

Authors:  Joel Jihwan Hwang; Jinhyeok Choi; Yeri Alice Rim; Yoojun Nam; Ji Hyeon Ju
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

8.  Comparative evaluation of isogenic mesodermal and ectomesodermal chondrocytes from human iPSCs for cartilage regeneration.

Authors:  Ming-Song Lee; Matthew J Stebbins; Hongli Jiao; Hui-Ching Huang; Ellen M Leiferman; Brian E Walczak; Sean P Palecek; Eric V Shusta; Wan-Ju Li
Journal:  Sci Adv       Date:  2021-05-19       Impact factor: 14.136

9.  A systematic dissection of human primary osteoblasts in vivo at single-cell resolution.

Authors:  Yun Gong; Junxiao Yang; Xiaohua Li; Cui Zhou; Yu Chen; Zun Wang; Xiang Qiu; Ying Liu; Huixi Zhang; Jonathan Greenbaum; Liang Cheng; Yihe Hu; Jie Xie; Xuecheng Yang; Yusheng Li; Yuntong Bai; Yu-Ping Wang; Yiping Chen; Li-Jun Tan; Hui Shen; Hong-Mei Xiao; Hong-Wen Deng
Journal:  Aging (Albany NY)       Date:  2021-08-24       Impact factor: 5.682

10.  Cartilage from human-induced pluripotent stem cells: comparison with neo-cartilage from chondrocytes and bone marrow mesenchymal stromal cells.

Authors:  Alejandro Rodríguez Ruiz; Amanda Dicks; Margo Tuerlings; Koen Schepers; Melissa van Pel; Rob G H H Nelissen; Christian Freund; Christine L Mummery; Valeria Orlova; Farshid Guilak; Ingrid Meulenbelt; Yolande F M Ramos
Journal:  Cell Tissue Res       Date:  2021-07-09       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.